临床经验
Copyright ©The Author(s) 2012.
世界华人消化杂志. 2012-09-18; 20(26): 2529-2533
在线出版 2012-09-18. doi: 10.11569/wcjd.v20.i26.2529
表1 不同分组中血清IGF-1、IGFBP-3水平及IGF-1/IGFBP-3比值 (mean±SD)
分组nIGF-1(μg/L)IGFBP-3(μg/L)IGF-1/IGFBP-3
CRC组48247.35±60.77a3902.59±415.660.063±0.010a
CRA组120224.75±69.45a4061.48±683.910.055±0.010a
健康对照组34195.39±63.374101.04±710.320.047±0.013
表2 腺瘤性息肉患者血清IGF-1、IGFBP-3及IGF-1/IGFBP-3与临床参数的关系 (mean±SD)
项目nIGF-1(μg/L)t(F)PIGFBP-3(μg/L)t(F)PIGF-1/IGFBP-3t(F)P
性别
69217.06±64.13-1.4160.1593977.54±674.49-1.5730.1180.054±0.0090.8340.407
51235.14±75.464175.03±686.740.056±0.012
年龄(岁)
≥6051230.95±69.710.840.4034039.48±713.91-0.3020.1730.057±0.011-1.8530.066
<6069220.16±69.404077.74±665.680.054±0.010
吸烟情况0.4070.274
从未吸93221.22±67.840.9074007.61±633.651.3030.054±0.0110.7840.459
持续吸15247.24±78.884269.93±840.190.058±0.011
曾经吸12223.98±70.514218.36±832.310.053±0.010
饮酒史0.948
99221.98±67.120.9450.3464059.58±658.660.0660.054±0.0111.3390.183
21237.76±80.054070.43±810.610.057±0.010
肿瘤家族史
15214.16±68.34-0.6290.534027.90±773.86-0.2020.8400.055±0.0111.2440.226
105226.26±69.804066.27±674.080.052±0.007
表3 CRA患者血清IGF-1、IGFBP-3水平及IGF-1/IGFBP-3比值与临床病理参数的关系 (mean±SD)
项目nIGF-1(μg/L)t(F)PIGFBP-3(μg/L)t(F)PIGF-1/IGFBP-3t(F)P
息肉直径大小
≤1 cm60223.49±64.300.1250.8824073.25±664.700. 9700.9070.054±0.0100.8730.42
≥3 cm27230.60±69.124010.38±658.250.057±0.011
1-3 cm33222.24±79.954081.88±754.840.054±0.012
息肉数量
多个51235.29±81.791.3360.1754087.98±784.150.3500.7270.056±0.0121.6710.098
单个69216.94±58.114041.89±604.550.053±0.010
息肉部位219.24±62.234032.00±651.88
结肠103233.57±121.282.8130.0644011.47±422.121.0730.3450.054±0.0102.3950.096
直肠5268.35±92.344335.35±981.670.056±0.022
直结肠120.061±0.010
息肉组织学分类
管状腺瘤92217.72±62.812.5000.0863999.72±690.151.6250.2010.053±0.0102.0090.139
绒毛状腺瘤18256.80±86.344262.81±469.400.059±0.015
管状绒毛状腺瘤10231.69±84.764267.26±886.040.054±0.009
表4 各组中血清IGF-1、IGFBP-3水平及IGF-1/IGFBP-3比值 (mean±SD)
分组nIGF-1(μg/L)IGFBP-3(μg/L)IGF-1/IGFBP-3
CRC组48247.35±60.77a3902.59±415.660.063±0.010a
进展期腺瘤组72235.81±73.72a4143.77±702.020.056±0.011a
早期腺瘤组48208.15±59.443938.03±643.270.052±0.008

引文著录: 崔艳欣, 姜常青, 王瑶, 姜相君, 辛永宁, 宋明全. 结直肠腺瘤患者血清IGF-1和IGFBP-3的变化及其临床意义. 世界华人消化杂志 2012; 20(26): 2529-2533